Annual Cash & Cash Equivalents:
$275.24M+$101.52M(+58.44%)Summary
- As of today (October 4, 2025), DNTH annual cash & cash equivalents is $275.24 million, with the most recent change of +$101.52 million (+58.44%) on December 31, 2024.
- During the last 3 years, DNTH annual cash & cash equivalents has risen by +$98.31 million (+55.57%).
- DNTH annual cash & cash equivalents is now at all-time high.
Performance
DNTH Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$257.39M-$5.84M(-2.22%)Summary
- As of today (October 4, 2025), DNTH quarterly cash & cash equivalents is $257.39 million, with the most recent change of -$5.84 million (-2.22%) on June 30, 2025.
- Over the past year, DNTH quarterly cash & cash equivalents has dropped by -$103.32 million (-28.64%).
- DNTH quarterly cash & cash equivalents is now -31.73% below its all-time high of $377.04 million, reached on March 31, 2024.
Performance
DNTH Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DNTH Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +58.4% | -28.6% |
| 3Y3 Years | +55.6% | +84.6% |
| 5Y5 Years | +88.9% | +45.8% |
DNTH Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +264.6% | -31.7% | +241.0% |
| 5Y | 5-Year | at high | +264.6% | -31.7% | +241.0% |
| All-Time | All-Time | at high | +5958.6% | -31.7% | +518.3% |
DNTH Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $257.39M(-2.2%) |
| Mar 2025 | - | $263.23M(-4.4%) |
| Dec 2024 | $275.24M(+58.4%) | $275.24M(-2.1%) |
| Sep 2024 | - | $281.12M(-22.1%) |
| Jun 2024 | - | $360.71M(-4.3%) |
| Mar 2024 | - | $377.04M(+117.0%) |
| Dec 2023 | $173.72M(+130.1%) | $173.72M(-8.5%) |
| Sep 2023 | - | $189.87M(+144.7%) |
| Jun 2023 | - | $77.59M(-3.0%) |
| Mar 2023 | - | $79.99M(+6.0%) |
| Dec 2022 | $75.49M(-57.3%) | $75.49M(-41.2%) |
| Sep 2022 | - | $128.28M(-8.0%) |
| Jun 2022 | - | $139.43M(-11.0%) |
| Mar 2022 | - | $156.60M(-11.5%) |
| Dec 2021 | $176.93M | - |
| Dec 2021 | - | $176.93M(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $192.62M(-7.3%) |
| Jun 2021 | - | $207.81M(+57.1%) |
| Mar 2021 | - | $132.29M(-11.1%) |
| Dec 2020 | $148.84M(+2.1%) | $148.84M(-8.0%) |
| Sep 2020 | - | $161.73M(-8.4%) |
| Jun 2020 | - | $176.50M(+35.3%) |
| Mar 2020 | - | $130.41M(-10.5%) |
| Dec 2019 | $145.73M(+2.2%) | $145.73M(-9.2%) |
| Sep 2019 | - | $160.57M(-6.8%) |
| Jun 2019 | - | $172.27M(+35.3%) |
| Mar 2019 | - | $127.31M(-10.7%) |
| Dec 2018 | $142.57M(+176.5%) | $142.57M(-10.8%) |
| Sep 2018 | - | $159.84M(-7.9%) |
| Jun 2018 | - | $173.59M(+317.0%) |
| Mar 2018 | - | $41.63M |
| Dec 2017 | $51.57M(+1035.1%) | - |
| Dec 2016 | $4.54M | - |
FAQ
- What is Dianthus Therapeutics, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Dianthus Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Dianthus Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of DNTH is $275.24M
What is the all-time high annual cash & cash equivalents for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high annual cash & cash equivalents is $275.24M
What is Dianthus Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, DNTH annual cash & cash equivalents has changed by +$101.52M (+58.44%)
What is Dianthus Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DNTH is $257.39M
What is the all-time high quarterly cash & cash equivalents for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $377.04M
What is Dianthus Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, DNTH quarterly cash & cash equivalents has changed by -$103.32M (-28.64%)